ESAs to treat anemia-balancing the risks and benefits

被引：9

作者：

Glaspy, John ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Dept Hematol Oncol, Los Angeles, CA 90095 USA

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2009年 / 6卷 / 09期

关键词：

CANCER-PATIENTS; ERYTHROPOIETIN; CHEMOTHERAPY; METAANALYSIS; ALPHA;

D O I：

10.1038/nrclinonc.2009.126

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：500 / 502

页数：3

共 9 条

[1]

[Anonymous], COMP EFFECTIVENESS R

[2] Erythropoietin or Darbepoetin for patients with cancer [J].

Bohlius, J. ;

Wilson, J. ;

Seidenfeld, J. ;

Piper, M. ;

Schwarzer, G. ;

Sandercock, J. ;

Trelle, S. ;

Weingart, O. ;

Bayliss, S. ;

Brunskill, S. ;

Djulbegovic, B. ;

Benett, C. L. ;

Langensiepen, S. ;

Hyde, C. ;

Engert, E. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03)

[3] Recombinant human erythropoietin and overall survival in cancer patients: Results of a comprehensive meta-analysis [J].

Bohlius, J ;

Langensiepen, S ;

Schwarzer, G ;

Seidenfeld, J ;

Piper, M ;

Bennett, C ;

Engert, A .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) :489-498

[4] Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients [J].

Bohlius, Julia ;

Wilson, Jayne ;

Seidenfeld, Jerome ;

Piper, Margaret ;

Schwarzer, Guido ;

Sandercock, Josie ;

Trelle, Sven ;

Weingart, Olaf ;

Bayliss, Sue ;

Djulbegovic, Benjamin ;

Bennett, Charles L. ;

Langensiepen, Simon ;

Hyde, Chris ;

Engert, Andreas .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (10) :708-714

[5] Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials [J].

Bohlius, Julia ;

Schmidlin, Kurt ;

Brillant, Corinne ;

Schwarzer, Guido ;

Trelle, Sven ;

Seidenfeld, Jerome ;

Zwahlen, Marcel ;

Clarke, Michael ;

Weingart, Olaf ;

Kluge, Sabine ;

Piper, Margaret ;

Rades, Dirk ;

Steensma, David P. ;

Djulbegovic, Benjamin ;

Fey, Martin F. ;

Ray-Coquard, Isabelle ;

Machtay, Mitchell ;

Moebus, Volker ;

Thomas, Gillian ;

Untch, Michael ;

Schumacher, Martin ;

Egger, Matthias ;

Engert, Andreas .

LANCET, 2009, 373 (9674) :1532-1542

[6] Erythropoietin in Cancer Patients [J].

Glaspy, John A. .

ANNUAL REVIEW OF MEDICINE, 2009, 60 :181-192

[7]

Glaspy John A, 2008, J Natl Compr Canc Netw, V6, P565

[8] Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study [J].

Leyland-Jones, B ;

Semiglazov, V ;

Pawlicki, M ;

Pienkowski, T ;

Tjulandin, S ;

Manikhas, G ;

Makhson, A ;

Roth, A ;

Dodwell, D ;

Baselga, J ;

Biakhov, M ;

Valuckas, K ;

Voznyi, E ;

Liu, XY ;

Vercammen, E .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5960-5972

[9] Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study [J].

Smith, Robert E. ;

Aapro, Matti S. ;

Ludwig, Heinz ;

Pinter, Tamas ;

Smakal, Martin ;

Ciuleanu, Tudor E. ;

Chen, Li ;

Lillie, Tom ;

Glaspy, John A. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) :1040-1050

← 1 →